PDLIM2 and prostate cancer: The inhibition of PDLIM2 resulted in a reduced number and weakened viability, proliferation, and clonal growth of prostate cancer cells; furthermore, PDLIM2 may play a carcinogenic role in human CRPC-like cells [10].